CiteFacts · FDA Drug Shortages · FDA source
Dopamine Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Available | 08/17/2026 |
| Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Available | 08/17/2026 |
| Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Available | 08/17/2026 |
| Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Available | 08/17/2026 |
| Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Unavailable | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24) | Not stated | 08/27/2025 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Available | 08/07/2026 |
Source facts
Grouped generic ingredient: Dopamine Hydrochloride Injection · 12 package records · Latest FDA row update: 08/27/2025
Therapeutic categories: Cardiovascular
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.